Afuco™ Anti-IL17 ADCC Recombinant Antibody (Afasevikumab), ADCC Enhanced (CAT#: AFC-TAB-474CQ)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL17. Afasevikumab is a human monoclonal antibody that can be potentially used in the treatment of Multiple sclerosis (MS).


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human IL17A and IL17F
  • Species Reactivity
  • Human
  • Clone
  • Afasevikumab
  • Applications
  • ELISA, IHC, FC, IP, IF, Inhib
  • Conjugate
  • Unconjugated
  • Generic Name
  • Afasevikumab
  • Related Disease
  • Multiple sclerosis (MS)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Afasevikumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Afasevikumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Afasevikumab"

Anti-Human IL17 Recombinant Antibody (Afasevikumab)
Recombinant monoclonal antibody to IL17. Afasevikumab is a human monoclonal antibody that can be potentially used in the treatment of Multiple sclerosis (MS).

See other products for "IL17"

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-4244 Rabbit Anti-IL17 Recombinant Antibody (clone SI323DS) ELISA Rabbit IgG

Recombinant Antibody

CAT Product Name Application Type
HPAB-0238CQ Human Anti-IL17 Recombinant Antibody (HPAB-0238CQ) ELISA, Neut Humanized IgG1, κ
HPAB-0239CQ Mouse Anti-IL17 Recombinant Antibody (HPAB-0239CQ) ELISA, Neut Mouse IgG2b, κ
VS-0923-FY190 Recombinant Mouse Anti-IL17 Antibody (VS-0923-FY190) ELISA, WB, IHC Mouse IgG2b

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-474CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare